| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |